Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why BioNTech Leaped Nearly 7% Higher Today


Model coronavirus stock BioNTech (NASDAQ: BNTX) shot 6.6% higher Friday. This was due to encouraging news about the coronavirus vaccine BNT162b2, which it developed with Pfizer (NYSE: PFE). A big pronouncement by a major health authority also helped.

In a 175-participant study of elderly patients who had received both doses of the two-jab BNT162b2, British researchers found that it actually induces a stronger antibody response when the two shots are spaced further apart than recommended -- 12 weeks rather than the three of official guidance.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments